ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Bile Microbiology and Antibiotic Susceptibility in Liver Transplant Recipients versus Non-Transplant Population

    S. Suh, Y. Choi

    Surgery, Chung-Ang University Hospital, Seoul, Korea, Republic of

    *Purpose: The signs and symptoms of biliary infection in liver transplantation (LT) recipients are frequently subtle because of immunosuppression, thereby delaying its diagnosis and increasing…
  • 2020 American Transplant Congress

    Understanding Attitudes and Perceptions about Liver Disease and Living-Donor Liver Transplant- Results of a National Survey

    C. Zell1, C. Caruso1, T. Kirby2, S. Piccirilli3, S. Ganesh4, J. Whyte5, A. Humar3

    1Clinical Marketing, UPMC, Pittsburgh, PA, 2Marketing Intelligence, UPMC, Pittsburgh, PA, 3Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, 4Clinical Marketing, Thomas E. Starzl Transplantation Institute, Pittsburgh, PA, 5WebMD, New York, NY

    *Purpose: There are more than 14,000 people on the national waiting list for a liver transplant. Approximately 25% will die before receiving a life-saving transplant…
  • 2020 American Transplant Congress

    Using HCV Infected Organs and the Challenge of Third-Party Payers

    R. Daloul, A. Michaels, L. Sobotka, T. Pesavento, K. Washburn

    Comprhensive Transplant Center, The Ohio State University, Columbus, OH

    *Purpose: The practice of transplanting organs from hepatitis C viremic donors (HCV NAT+) into negative recipients hinges on the ability to ensure direct acting antiviral…
  • 2020 American Transplant Congress

    Characteristics of Early BK Viremia after Renal Transplantation at an Urban Academic Medical Center

    K. Kurzweil, K. Lamartina, K. Svaflarska, D. Kutrzuba, N. Fayyaz, O. Piatek, P. West-Thielke, Z. Hajjiri, I. Tzvetanov, E. Benedetti, A. Lichvar

    University of Illinois at Chicago, Chicago, IL

    *Purpose: BK viremia (BKV) is a deleterious complication after renal transplantation that can compromise allograft function. Centers face the challenge of identifying at-risk patients and…
  • 2020 American Transplant Congress

    Incidence and Risks Factors of Kidney Allograft Loss Due to BK Virus: UNOS Data Set

    H. Patel1, K. Agrawal1, A. Pawar1, N. Leeaphorn2, F. Cardarelli1, N. Agrawal1

    1Transplant Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, 2Transplant Nephrology, University of Missouri-Kansas City School of Medicine/Saint Luke's Health System, Kansas City, MO

    *Purpose: BK virus infection can lead to graft dysfunction and loss in kidney transplant patients. Incidence and prevalence of BK Viremia (BKV) and BK Virus…
  • 2020 American Transplant Congress

    Valganciclovir Prophylaxis is Not Associated with Polyomavirus Viremia after Renal Transplantation

    D. Conti1, D. Schuster1, M. Garner1, E. Maciera1, S. Patel2

    1Albany Medical Center, Albany, NY, 2Surgery, Albany Medical Center, Albany, NY

    *Purpose: Recent studies have implicated prophylactic valganciclovir (VGC) therapy after renal transplantation to be associated with an increased rate of BK polyomavirus viremia and nephropathy.…
  • 2020 American Transplant Congress

    Effect of JC Virus on Polyomavirus Nephropathy in Renal Transplant Recipients

    G. Huang, Y. Huang, X. Chen, J. Qiu, J. Li, C. Wang, L. Chen

    The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    *Purpose: To investigate the effect of JC virus (JCV) on the development and prognosis of BK virus (BKV) infection and polyomavirus nephropathy (PVN) in renal…
  • 2020 American Transplant Congress

    Transplanting Livers from Hepatitis C Virus Positive Donors; Is it Worth the Risk?

    J. W. Mensink1, B. Van Hoek2, B. Schaefer3, M. D. Van Rosmalen4, I. P. Alwayn5, A. E. Braat5

    1Leiden University Medical Center, Leiden, Netherlands, 2Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands, 3Dutch Transplant Foundation, Leiden, Netherlands, 4Eurotransplant International Foundation, Leiden, Netherlands, 5Transplant Surgery, Leiden University Medical Center, Leiden, Netherlands

    *Purpose: Before the introduction of Direct-Acting Antivirals (DAAs), only selected organs from Hepatitis C virus (HCV) positive donors were successfully transplanted into HCV positive recipients.…
  • 2020 American Transplant Congress

    Hematopoietic Cell Transplantation and Solid Organ Transplantation: Outcomes of Sequential Transplantation in the United States

    M. Gupta1, M. Levine2, D. Porter2, R. Brazauskas3, S. Bo-Subait4, R. Phelan3, M. Battiwalla5, D. Buchbinder6, B. Hamilton7, B. Shaw3, P. Abt2

    1University of Kentucky, Lexington, KY, 2University of Pennsylvania, Philadelphia, PA, 3Medical College of Wisconsin, Milwaukee, WI, 4CIBMTR, NMDP, Minneapolis, MN, 5Sarah Cannon Blood Cancer Network, Nashville, TN, 6Children's Hospital of Orange County, Orange, CA, 7Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH

    *Purpose: Survival after solid organ transplantation(SOT) and hematopoietic cell transplantation(HCT) has steadily risen. Despite these improvements, SOT recipients may develop conditions requiring HCT, and HCT…
  • 2020 American Transplant Congress

    Patient and Renal Outcomes of Post Transplant Lymphoproliferative Disorder Following Solid Organ Transplantations – A Single Center Experience

    G. Katz-Greenberg1, K. Mallari2, U. Martinez-Outschoorn1, M. P. MartinezCantarin1

    1Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, 2Thomas Jefferson University, Philadelphia, PA

    *Purpose: Posttransplant lymphoproliferative disorder (PTLD) remains an unfortunate complication in patients following solid organ transplantation (SOT) and hematopoietic stem cells transplantations. The diagnosis of PTLD…
  • « Previous Page
  • 1
  • …
  • 430
  • 431
  • 432
  • 433
  • 434
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences